| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6313262 | Environment International | 2015 | 21 Pages |
Abstract
Further epidemiological studies are required during pregnancy to i) determine the role of phthalates other than DEHP [currently replaced by various substitution products, in particular diisononyl-phthalate (DiNP)]; ii) establish the effect of phthalates on other outcomes (body size adjusted for gestational age, and congenital malformations); iii) determine the pathophysiological pathways; and iv) identify the most suitable time for biomarker determination of in utero exposure to phthalates.
Keywords
OEPAGIMaternal urineINSL3CHDPPARsendocrine disruptersBiomarkerTriiodothyroninethyroxineJEMCord bloodIn utero exposurebody mass indexBMIORAInsulin-like factor 3Anogenital distanceconfidence intervalPhthalatesnot detectableJob-exposure matrixamniotic fluidadjusted odds ratioodds ratioCongenital heart defectsMolecular weightBirth weightPVCpregnancy outcomesAGDPolyvinyl chloridePeroxisome proliferator activated receptor
Related Topics
Life Sciences
Environmental Science
Environmental Chemistry
Authors
Cécile Marie, Françoise Vendittelli, Marie-Pierre Sauvant-Rochat,